In another study, in lymphoma-bearing mice, the use of vaccines against an epitope of C5a receptor (C5aR) on antigen-presenting cells (APCs) showed impressive protective outcomes against an aggressive murine lymphoma. Here, C5AR1 is linked to lymphoma.